Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
Singapore
National Cancer Center Singapore, Singapore Last updated September 2025